Omar Alkharabsheh/LinkedIn
Aug 21, 2026, 10:33
Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
Omar Alkharabsheh, Medical Director at Orlando Health shared a post on LinkedIn:
”I’m excited to share that I’ve recently moved to Orlando and joined Orlando Health Cancer Institute as the Medical Director of the Hematology Center of Excellence.
I took this exciting opportunity to build and expand the hematologic malignancies program, with a vision to bring innovative therapies and cutting-edge clinical research to patients in central Florida. I look forward to working with an exceptional multidisciplinary team to advance the care of patients, expand access to clinical trials, and help take the program to new levels of excellence.”
Stay updated with Hemostasis Today.
-
Oct 12, 2026, 13:58Francisco Chacón-Lozsán: Catastrophic Antiphospholipid Syndrome A Rapidly Progressive Multiorgan Thrombotic Emergency
-
Oct 12, 2026, 12:50Nawsherwan Mohammad: Study Examines Thrombotic Events in Patients with Polycythemia Vera in Iraq
-
Oct 12, 2026, 12:30Chanakya Nayudu: Looking Beyond Blood Clots – Patient-Reported Outcomes in Antiphospholipid Syndrome
-
Oct 12, 2026, 12:12Jean-Jacques Kiladjian: Improving Treatment Strategies with JAK Inhibitors in Myelofibrosis
-
Oct 12, 2026, 12:04Chloe Homich: AABB Annual Meetings – Building Connections and Advancing Transfusion Medicine
-
Oct 12, 2026, 11:51Daniel Sop: Sickle Cell Research Takes Center Stage at ASCAT 2026
-
Oct 12, 2026, 10:36PAI-1 Inhibition as a New Strategy for Enhancing Fibrinolysis and Clot Resolution
-
Oct 12, 2026, 07:39Emmanuel J Favaloro: 100 Years of von Willebrand Disease and the Importance of Local Diagnosis and Management
-
Oct 12, 2026, 07:39Post-Stroke Fatigue Trajectories – 38% Recovered at 12 Months, While 16% Developed New Fatigue – International Journal of Stroke